跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-APIXABAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-APIXABAN
Authorized
STANDARD
AURO-APIXABAN
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b7c4e88b331d1542
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
b7c4e88b331d1542
Drug Approval Canada Name
AURO-APIXABAN
Product Name
AURO-APIXABAN
Status
Marketed
Status Date
2022-11-28
Original Market Date
2022-11-28
Din
02486806
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF02 APIXABAN
Atc Name
b 01 af 02
Aig Number
0153051001
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
APIXABAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b7c4e88b331d1542
Type
Standard
Back to Health Canada Approvals